aliciatng
2021-12-23
Okay
Ortho Clinical Diagnostics shares surged 11% in premarket trading
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
2
4
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":698087016,"tweetId":"698087016","gmtCreate":1640263195479,"gmtModify":1640263196539,"author":{"id":3572214398550610,"idStr":"3572214398550610","authorId":3572214398550610,"authorIdStr":"3572214398550610","name":"aliciatng","avatar":"https://static.tigerbbs.com/c4b23ee891a1061c7907495a9c7da890","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":104,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Okay</p></body></html>","htmlText":"<html><head></head><body><p>Okay</p></body></html>","text":"Okay","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/698087016","repostId":1179225984,"repostType":4,"repost":{"id":"1179225984","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640262946,"share":"https://www.laohu8.com/m/news/1179225984?lang=&edition=full","pubTime":"2021-12-23 20:35","market":"us","language":"en","title":"Ortho Clinical Diagnostics shares surged 11% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1179225984","media":"Tiger Newspress","summary":"Ortho Clinical Diagnostics shares surged 11% in premarket trading.\nQuidel Corporation(NASDAQ:QDEL)ha","content":"<p>Ortho Clinical Diagnostics shares surged 11% in premarket trading.<img src=\"https://static.tigerbbs.com/d23b5b89b89ee4bfdc55d23585e0005f\" tg-width=\"700\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Quidel Corporation(NASDAQ:QDEL)has agreed to acquire Ortho Clinical Diagnostics(NASDAQ:OCDX)for $24.68 per share of common stock for a total equity value of nearly $6B, the companies announced Thursday. Both Ortho Clinical (OCDX) and Quidel (QDEL) shares are currently on hold for trading.</p>\n<p>According to the definitive agreement signed by the parties, Quidel (QDEL) has offered cash and newly issued shares in the combined company indicating a 25% premium for Ortho’s closing price on Dec. 22, 2022.</p>\n<p>Per the terms, for each Ortho (OCDX) share they won, Ortho investors are set to receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined entity. They will own nearly 38% of the combined company, which will be led by Quidel’s current President and CEO, Douglas Bryant.</p>\n<p>With the acquisition of Ortho Clinical (OCDX), a player in vitro diagnostic, Quidel (QDEL) expects to generate an estimated $90M cost synergies by year three in the combined company. The deal is also anticipated to yield revenue synergies over $100M by 2025 and opportunitiesfor adjusted EBITDA margin expansion.</p>\n<p>A few days ago, JPMorgan identified Quidel (QDEL) as one of its top picks to short in 2022.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ortho Clinical Diagnostics shares surged 11% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrtho Clinical Diagnostics shares surged 11% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-23 20:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ortho Clinical Diagnostics shares surged 11% in premarket trading.<img src=\"https://static.tigerbbs.com/d23b5b89b89ee4bfdc55d23585e0005f\" tg-width=\"700\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p>Quidel Corporation(NASDAQ:QDEL)has agreed to acquire Ortho Clinical Diagnostics(NASDAQ:OCDX)for $24.68 per share of common stock for a total equity value of nearly $6B, the companies announced Thursday. Both Ortho Clinical (OCDX) and Quidel (QDEL) shares are currently on hold for trading.</p>\n<p>According to the definitive agreement signed by the parties, Quidel (QDEL) has offered cash and newly issued shares in the combined company indicating a 25% premium for Ortho’s closing price on Dec. 22, 2022.</p>\n<p>Per the terms, for each Ortho (OCDX) share they won, Ortho investors are set to receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined entity. They will own nearly 38% of the combined company, which will be led by Quidel’s current President and CEO, Douglas Bryant.</p>\n<p>With the acquisition of Ortho Clinical (OCDX), a player in vitro diagnostic, Quidel (QDEL) expects to generate an estimated $90M cost synergies by year three in the combined company. The deal is also anticipated to yield revenue synergies over $100M by 2025 and opportunitiesfor adjusted EBITDA margin expansion.</p>\n<p>A few days ago, JPMorgan identified Quidel (QDEL) as one of its top picks to short in 2022.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QDEL":"窥得儿医药","OCDX":"Ortho Clinical Diagnostics Holdings plc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179225984","content_text":"Ortho Clinical Diagnostics shares surged 11% in premarket trading.\nQuidel Corporation(NASDAQ:QDEL)has agreed to acquire Ortho Clinical Diagnostics(NASDAQ:OCDX)for $24.68 per share of common stock for a total equity value of nearly $6B, the companies announced Thursday. Both Ortho Clinical (OCDX) and Quidel (QDEL) shares are currently on hold for trading.\nAccording to the definitive agreement signed by the parties, Quidel (QDEL) has offered cash and newly issued shares in the combined company indicating a 25% premium for Ortho’s closing price on Dec. 22, 2022.\nPer the terms, for each Ortho (OCDX) share they won, Ortho investors are set to receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined entity. They will own nearly 38% of the combined company, which will be led by Quidel’s current President and CEO, Douglas Bryant.\nWith the acquisition of Ortho Clinical (OCDX), a player in vitro diagnostic, Quidel (QDEL) expects to generate an estimated $90M cost synergies by year three in the combined company. The deal is also anticipated to yield revenue synergies over $100M by 2025 and opportunitiesfor adjusted EBITDA margin expansion.\nA few days ago, JPMorgan identified Quidel (QDEL) as one of its top picks to short in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":286,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/698087016"}
精彩评论